Sep. 16 at 8:12 AM
$ENLV Enlivex narrowed its Q2 net loss to
$1.87M from
$3.1M last year, reducing burn as Allocetra delivers strong clinical wins. https://biotechhealthx.com/biotech-news/enlivex-enlv-reports-1-87m-q2-loss-cuts-cash-burn-nearly-40/